Back to PE Pentwater Capital Management LP

APGEAPGE

2 quarters

Position history for PEPentwater Capital Management LP's holdings in APOGEE THERAPEUTICS INC

As of its Q2 2026 13F, Pentwater Capital Management held 1,425,000 shares of APGE (Apogee Therapeutics), worth $189.1M. APGE was 1.2% of Pentwater Capital Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$189.1M

Total Shares Change

-1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2026-Q2
New
1.4M
—
$189.1M1.2%$132.73
70

Optional analytics helps us improve. How it’s used